Complex functions of mutant p53 alleles from human prostate cancer

The Prostate
Xu-Bao ShiR W deVere White

Abstract

Few studies have used multiple assays to examine the functionality of mutant p53 in prostate cancer (CaP). We employed seven functional assays to study 16 representative mutant p53 alleles, six from localized and ten from metastatic CaP. Yeast assays were employed to determine loss of function (LOF), partial function (PF), and dominant-negative status. Assays using p53-null Saos2 cells were used to determine whether mammalian cells transfected with mutant p53 could up-regulate the MDR-1 or PCNA promoters, alter IL-6 expression or confer the ability to grow in soft agar. As a further test of gain of function (GOF), p53-null PC3 cells stably transfected with these mutant p53 alleles were examined for cell cycle distributions. All 16 mutant p53 alleles demonstrated either total or partial LOF. All but one allele also had at least one gain of function; however, the pattern of GOF was different for each mutant allele. Alleles derived from both localized and metastatic CaP had similar GOF characteristics; however, only alleles from metastatic disease had significantly increased S-phase fractions. Different mutant p53 alleles from CaP had different, complex functional profiles. The lack of predictable patterns for these alleles sugges...Continue Reading

References

Aug 1, 1992·Journal of Virology·M A SublerS Deb
Jun 6, 1991·Nature·A J LevineC A Finlay
Jun 15, 1994·Journal of the National Cancer Institute·S G ChiP H Gumerlock
Oct 20, 1993·Journal of the National Cancer Institute·N M NavoneC J Conti
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·J M FlamanJ Benhattar
Jan 27, 1995·The Journal of Biological Chemistry·M E GoldsmithK H Cowan
Feb 1, 1994·The Journal of Urology·H J VoellerE P Gelmann
May 1, 1993·Nature Genetics·D DittmerA J Levine
Dec 1, 1995·Molecular and Cellular Biology·C V ShivakumarS P Deb
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·R K BrachmannJ D Boeke
Aug 1, 1997·Molecular Carcinogenesis·L Q JiaT Kuroki
Dec 31, 1997·Science·R F BonnerL A Liotta
Feb 7, 1998·The Journal of Biological Chemistry·M L AgarwalG R Stark
Feb 7, 1998·Molecular Medicine Today·P Roy-BurmanG J Miller
May 23, 1998·The Journal of Urology·R W deVere WhiteS L Stewart
Jul 4, 1998·British Journal of Cancer·F Ponchel, J Milner
Aug 12, 1998·Journal of Molecular Biology·P Chène
Mar 5, 1999·Cellular and Molecular Life Sciences : CMLS·S Bates, K H Vousden
Mar 29, 2000·CA: a Cancer Journal for Clinicians·R T GreenleeP A Wingo
Apr 14, 2000·Frontiers in Bioscience : a Journal and Virtual Library·K Somasundaram
Dec 1, 2000·Nature·B VogelsteinA J Levine

❮ Previous
Next ❯

Citations

Jun 6, 2003·Cancer Treatment Reviews·Cynthia L MartelPrimo N Lara
Jan 23, 2003·Cancer Biotherapy & Radiopharmaceuticals·Xu-Bao ShiRalph W deVere White
Feb 20, 2016·Drug Discovery Today·Sara GomesLucília Saraiva
Feb 6, 2007·British Journal of Haematology·Andrew J DaviesT Andrew Lister
Feb 14, 2012·International Journal of Urology : Official Journal of the Japanese Urological Association·Konstantinos TsapakidisChristos N Papandreou
Jul 29, 2004·Annales D'urologie·C Linke, P Mongiat-Artus
Sep 11, 2004·Biochemical and Biophysical Research Communications·Xiaoqin XiangZhijun Luo
Dec 17, 2011·Bioorganic & Medicinal Chemistry Letters·Shaohua ChangKe Ding
Nov 22, 2012·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·V R KatkooriW E Grizzle
Mar 22, 2014·Cancer Cell·Patricia A J Muller, Karen H Vousden
Aug 5, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Xiang LiuJames S Norris
Mar 6, 2019·Cold Spring Harbor Molecular Case Studies·Peter HorakThorsten Schlomm
Dec 31, 2019·Cellular and Molecular Life Sciences : CMLS·Jiyeon Seo, Mikyoung Park
May 18, 2018·Nature Reviews. Urology·Richard B BerishHon S Leong
Oct 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ruth L VinallRalph W de Vere White
May 31, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alexandra M BleeHaojie Huang
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert MandicJochen A Werner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.